A Patient with a Novel Gene Mutation Leading to Autosomal Dominant Polycystic Kidney Disease.
A Patient with a Novel Gene Mutation Leading to Autosomal Dominant Polycystic Kidney Disease. Clin J Am Soc Nephrol. 2017 10 06; 12(10):1695-1698.
PMID: 28784653
Mutations in GANAB, Encoding the Glucosidase IIa Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease.
Mutations in GANAB, Encoding the Glucosidase IIa Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease. Am J Hum Genet. 2016 06 02; 98(6):1193-1207.
PMID: 27259053
The spectrum of autosomal dominant polycystic kidney disease in children and adolescents.
The spectrum of autosomal dominant polycystic kidney disease in children and adolescents. Pediatr Nephrol. 2017 01; 32(1):31-42.
PMID: 27034070
Acute Response to Tolvaptan in ADPKD: A Window to Predict Long-term Efficacy?
Acute Response to Tolvaptan in ADPKD: A Window to Predict Long-term Efficacy? Am J Kidney Dis. 2015 Jun; 65(6):811-3.
PMID: 26003607
Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy.
Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy. Ann Pharmacother. 2005 Oct; 39(10):1601-5.
PMID: 16131539
Argatroban and renal replacement therapy in patients with heparin-induced thrombocytopenia.
Argatroban and renal replacement therapy in patients with heparin-induced thrombocytopenia. Ann Pharmacother. 2005 Feb; 39(2):231-6.
PMID: 15632219
A prospective comparison of three argatroban treatment regimens during hemodialysis in end-stage renal disease.
A prospective comparison of three argatroban treatment regimens during hemodialysis in end-stage renal disease. Kidney Int. 2004 Dec; 66(6):2446-53.
PMID: 15569338